Seller record · Telehealth service

AM Rx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The answers and the subscriptions policy refer only to partner pharmacies, and one answer to an AM Rx Pharmacy with no location. 2 more criteria also fail; see the table below.

At a glance

AM RxTelehealth service

5/8criteria passed

Price: Compounded semaglutide from $106 a month on a three-month supply, plus a membership of $39 for the first month, then $135 a month
Sells: compounded semaglutide, compounded tirzepatide, Ozempic, and 7 more
FDA letters: 1 on file

Visit AM Rx See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth membership service for weight loss, primary care, mental health, birth control, hair loss, skin care and erectile dysfunction that sells compounded semaglutide and tirzepatide and helps members get brand GLP-1 medications covered by insurance.

Operating entity AM Rx, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	AM Rx's weight loss FAQ
S2	Prescription gating	PASS	AM Rx's website; AM Rx's weight loss page; AM Rx's weight loss FAQ
S3	Pharmacy identification	FAIL	AM Rx's weight loss FAQ; AM Rx's FAQ; AM Rx's subscriptions cancellations refunds policy
S4	Compounding disclosure	FAIL	AM Rx's weight loss page; AM Rx's weight loss FAQ
S5	Analytical documentation	FAIL	AM Rx's weight loss page; AM Rx's weight loss FAQ; AM Rx's subscriptions cancellations refunds policy
S6	Business address	PASS	AM Rx's contact page; AM Rx's privacy policy
S7	Price disclosure	PASS	AM Rx's weight loss FAQ; AM Rx's FAQ; AM Rx's weight loss page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe weight-loss answers say providers are United States licensed, board-certified physicians and nurse practitioners, and that a licensed provider reviews each intake and prescribes only when clinically appropriate. No individual prescriber is named.Source: AM Rx's weight loss FAQ.

S2PASSThe steps list answering health questions to check eligibility first and a provider's review second, and the answers say medication is charged only if it is prescribed, with payment processed after the provider sends the prescription to a partner pharmacy.Source: AM Rx's website; AM Rx's weight loss page; AM Rx's weight loss FAQ.

S3FAILNo filling pharmacy is named. The answers and the subscriptions policy refer only to partner pharmacies, and one answer to an AM Rx Pharmacy with no location.Source: AM Rx's weight loss FAQ; AM Rx's FAQ; AM Rx's subscriptions cancellations refunds policy.

S4FAILThe answers name compounded semaglutide and tirzepatide, and no page states that compounded products are not FDA-approved. The weight-loss page describes semaglutide as the active ingredient in Ozempic and Wegovy and says GLP-1 medications with semaglutide are FDA-approved for type 2 diabetes.Source: AM Rx's weight loss page; AM Rx's weight loss FAQ.

S5FAILNo certificate of analysis or lot document is published on the weight-loss page, the answers or the subscriptions policy.Source: AM Rx's weight loss page; AM Rx's weight loss FAQ; AM Rx's subscriptions cancellations refunds policy.

S6PASSAM Rx, LLC at 8 The Green, Dover, DE 19901, printed in the footer of every page, on the contact page and in the privacy policy.Source: AM Rx's contact page; AM Rx's privacy policy.

S7PASSThe weight-loss membership costs $39 for the first month for a limited time, with the standard membership at $135 a month, and medication costs extra. Compounded semaglutide starts at $106 a month and compounded tirzepatide at $216 a month on a three-month supply. Bundles with the medication included cost $217 for the first month, then $297 a month for semaglutide, and $349 for the first month, then $449 a month for tirzepatide. Insured brand GLP-1 copays can be as low as $25 a month.Source: AM Rx's weight loss FAQ; AM Rx's FAQ; AM Rx's weight loss page.

S8PASSFDA warning letter 728275, June 2026, names FitRX, LLC doing business as AM RX, reviews this website and writes to the support address it prints, at a New York address the site does not print. It says pictured labels named AM Rx as the compounder of semaglutide and tirzepatide products and that claims tying semaglutide to Ozempic and Wegovy present the compounded products as FDA-approved. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, Ozempic, Wegovy, Zepbound, Mounjaro, enclomiphene, birth control, hair loss and erectile dysfunction medications, mental health prescriptions.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 728275, issued June 2026, to FitRX, LLC dba AM RXPictured labels identify AM Rx as the compounder of semaglutide and tirzepatide products when it is not, and claims that semaglutide is the same active ingredient as Ozempic and Wegovy represent the compounded products as FDA-approved when they have not been.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit AM Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.